ThyCARE (Thyroid and Thyroid CAncer REsearch)

Addressing thyroid health and improving the care of patients across the thyroid cancer continuum

Pictured above: Elizabeth Hesseltine, NP, Frank Worden, MD
Pictured above: Mousumi Banerjee, PhD, Megan Haymart, MD
The goal of ThyCARE is to improve patient care through research. There are two teams committed to thyroid clinical research:

1) Thyroid health services research. Dr. Haymart and the health services research team focus on research topics related to diagnosis, prognosis, management, and survivorship. The team's goal is to improve thyroid care and communication. The health services research team has experience with large national cancer registries, population based studies, and survey studies.

2) Thyroid cancer clinical trials. For over a decade, Dr. Worden has led the thyroid cancer clinical trials team at the University of Michigan. Clinical trials offer potential benefits to patients with advanced thyroid cancer. It is important for patients with advanced thyroid cancer to have treatment options readily available and to have a team of caregivers who are trained to manage these complex patients. Only through trials with novel therapeutics can we improve survival.


Collaborators include:

        • endocrinologists

        • oncologists

        • surgeons

        • geriatricians

        • primary care physicians

        • biostatisticians

        • health economists

        • epidemiologists

        • survey methodologists



Topics that can be addressed with the research:

        • The rise in thyroid cancer incidence and its implications

        • Quality of care

        • Decreasing low-value care

        • Variation in management

        • The role of physicians, patients, and caregivers in treatment decisions

        • Communication between physicians and patients

        • Thyroid cancer outcomes

        • Thyroid and aging

        • Thyroid conditions in vulnerable patient groups

        • Disparities in thyroid care

        • Use of imaging in thyroid cancer

        • Interventions to improve care

        • Resource utilization

        • Trial eligibility and enrollment

        • Novel agents to treat advanced thyroid cancer

        • Survivorship

Dr. Frank Worden

Questions or Comments? Please contact Brittany Gay